Back to search

Article

A small molecule inhibitor of RNA-binding protein IGF2BP3 shows anti-leukemic activity

2025-04-18

Abstract excerpt

The RNA-binding protein IGF2BP3 is an oncofetal protein overexpressed in B-acute lymphoblastic leukemia and is critical for leukemogenesis in experimental models. With cancer-specific expression, functional dispensability for normal development, and an unleveraged pro-oncogenic function in mRNA homeostasis, IGF2BP3 represents an excellent target. With no small molecule inhibitors of IGF2BP3 in clinical use, we und...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
40a841d5-3bba-52f4-97fc-e2e642112afb
DOI
10.1101/2025.04.14.648780
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A small molecule inhibitor of RNA-binding protein IGF2BP3 shows anti-leukemic activityDOI 10.1101/2025.04.14.648780
Select a neighboring publication to make it the new centre.